Decision-making in stereotactic epilepsy surgery.
Kai J MillerAnthony L FinePublished in: Epilepsia (2022)
Surgery can cure or significantly improve both the frequency and the intensity of seizures in patients with medication-refractory epilepsy. The set of diagnostic and therapeutic interventions involved in the path from initial consultation to definitive surgery is complex and includes a multidisciplinary team of neurologists, neurosurgeons, neuroradiologists, and neuropsychologists, supported by a very large epilepsy-dedicated clinical architecture. In recent years, new practices and technologies have emerged that dramatically expand the scope of interventions performed. Stereoelectroencephalography has become widely adopted for seizure localization; stereotactic laser ablation has enabled more focal, less invasive, and less destructive interventions; and new brain stimulation devices have unlocked treatment of eloquent foci and multifocal onset etiologies. This article articulates and illustrates the full framework for how epilepsy patients are considered for surgical intervention, with particular attention given to stereotactic approaches.
Keyphrases
- minimally invasive
- coronary artery bypass
- temporal lobe epilepsy
- physical activity
- healthcare
- palliative care
- end stage renal disease
- brain metastases
- surgical site infection
- randomized controlled trial
- ejection fraction
- chronic kidney disease
- small cell lung cancer
- prognostic factors
- high intensity
- percutaneous coronary intervention
- working memory
- acute coronary syndrome
- coronary artery disease
- resting state
- rectal cancer
- locally advanced
- brain injury
- high speed
- adverse drug